Danaher (DHR) Projected to Post Earnings on Tuesday

Key Points

• Danaher will report Q1 2026 results before the market opens on April 21, with analysts projecting earnings of $1.94 per share and revenue of about $6.00 billion; the earnings call is scheduled for 8:00 AM ET.
• Danaher raised its quarterly dividend to $0.40 from $0.32, payable April 24 with an ex-dividend date of March 27, implying a $1.60 annualized payout and a 0.8% yield.
• In the last quarter the company beat expectations (EPS $2.23 vs. $2.14 estimate) with revenue of $6.84 billion (+4.6% YoY), and analysts maintain a consensus "Moderate Buy" with an average target of $249.60.

Danaher (NYSE:DHR - Get Free Report) is expected to be posting its Q1 2026 results before the market opens on Tuesday, April 21st. Analysts expect Danaher to post earnings of $1.94 per share and revenue of $6.0011 billion for the quarter. Individuals are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, April 21, 2026 at 8:00 AM ET.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business's revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.14 earnings per share. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Stock Performance

Shares of NYSE:DHR opened at $195.94 on Tuesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The business's 50 day moving average price is $200.48 and its 200-day moving average price is $214.79. The firm has a market capitalization of $138.66 billion, a PE ratio of 38.88, a P/E/G ratio of 2.57 and a beta of 0.95. Danaher has a 1 year low of $180.03 and a 1 year high of $242.80.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a $0.40 dividend. This is a boost from Danaher's previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. Danaher's dividend payout ratio is presently 31.75%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company's stock, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. GW&K Investment Management LLC boosted its position in shares of Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate's stock worth $138,000 after buying an additional 47 shares during the period. Kestra Private Wealth Services LLC boosted its position in shares of Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock worth $3,057,000 after buying an additional 48 shares during the period. Snowden Capital Advisors LLC boosted its position in shares of Danaher by 0.6% during the second quarter. Snowden Capital Advisors LLC now owns 9,919 shares of the conglomerate's stock worth $1,963,000 after buying an additional 55 shares during the period. Cloud Capital Management LLC boosted its position in shares of Danaher by 2.8% during the fourth quarter. Cloud Capital Management LLC now owns 2,112 shares of the conglomerate's stock worth $484,000 after buying an additional 57 shares during the period. Finally, CYBER HORNET ETFs LLC boosted its position in shares of Danaher by 3.6% during the third quarter. CYBER HORNET ETFs LLC now owns 1,750 shares of the conglomerate's stock worth $347,000 after buying an additional 61 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently commented on DHR. JPMorgan Chase & Co. increased their price target on Danaher from $270.00 to $275.00 and gave the company an "overweight" rating in a report on Thursday, January 29th. Evercore cut their price target on Danaher from $254.00 to $225.00 and set an "outperform" rating for the company in a report on Monday, April 6th. The Goldman Sachs Group cut their price target on Danaher from $265.00 to $230.00 and set a "buy" rating for the company in a report on Monday. Guggenheim increased their price target on Danaher from $250.00 to $275.00 and gave the company a "buy" rating in a report on Friday, January 2nd. Finally, Argus set a $265.00 price target on Danaher in a report on Wednesday, January 14th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and a consensus target price of $249.60.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.